VASN
Basic information
Region (hg38): 16:4371848-4383538
Previous symbols: [ "SLITL2" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the VASN gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 70 | 75 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 70 | 5 | 1 |
Variants in VASN
This is a list of pathogenic ClinVar variants found in the VASN region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-4380938-G-C | not specified | Uncertain significance (Dec 11, 2023) | ||
16-4380944-G-A | not specified | Uncertain significance (Jul 09, 2021) | ||
16-4380956-G-A | not specified | Uncertain significance (Dec 28, 2023) | ||
16-4380999-G-A | not specified | Uncertain significance (Oct 02, 2023) | ||
16-4381008-C-A | not specified | Uncertain significance (Nov 03, 2023) | ||
16-4381079-G-A | not specified | Uncertain significance (Apr 29, 2024) | ||
16-4381130-C-A | not specified | Uncertain significance (Dec 15, 2022) | ||
16-4381142-G-T | not specified | Uncertain significance (May 26, 2024) | ||
16-4381175-G-A | not specified | Uncertain significance (Jan 20, 2023) | ||
16-4381179-A-T | not specified | Uncertain significance (Dec 02, 2022) | ||
16-4381250-C-T | not specified | Uncertain significance (Jan 22, 2024) | ||
16-4381256-G-C | not specified | Uncertain significance (Nov 08, 2022) | ||
16-4381280-C-T | not specified | Uncertain significance (Dec 08, 2023) | ||
16-4381286-C-T | not specified | Uncertain significance (Jul 08, 2022) | ||
16-4381287-G-A | not specified | Likely benign (Sep 22, 2022) | ||
16-4381289-C-T | not specified | Uncertain significance (Aug 19, 2021) | ||
16-4381319-G-A | not specified | Uncertain significance (Jun 30, 2023) | ||
16-4381322-C-T | not specified | Uncertain significance (Aug 02, 2023) | ||
16-4381346-G-A | not specified | Uncertain significance (Jan 20, 2023) | ||
16-4381354-G-T | not specified | Uncertain significance (Mar 01, 2024) | ||
16-4381371-C-T | not specified | Uncertain significance (Jan 23, 2024) | ||
16-4381385-C-T | not specified | Uncertain significance (Dec 17, 2023) | ||
16-4381415-A-C | not specified | Uncertain significance (Jun 03, 2022) | ||
16-4381442-C-G | not specified | Uncertain significance (Oct 26, 2022) | ||
16-4381479-G-T | not specified | Uncertain significance (Nov 09, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
VASN | protein_coding | protein_coding | ENST00000304735 | 1 | 11681 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.672 | 0.327 | 124611 | 0 | 14 | 124625 | 0.0000562 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.295 | 411 | 428 | 0.960 | 0.0000310 | 4089 |
Missense in Polyphen | 102 | 121.31 | 0.8408 | 1394 | ||
Synonymous | -1.44 | 237 | 211 | 1.13 | 0.0000153 | 1599 |
Loss of Function | 2.72 | 2 | 12.3 | 0.163 | 6.95e-7 | 116 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000324 | 0.0000324 |
Ashkenazi Jewish | 0.000102 | 0.000100 |
East Asian | 0.0000556 | 0.0000545 |
Finnish | 0.000118 | 0.0000929 |
European (Non-Finnish) | 0.0000692 | 0.0000624 |
Middle Eastern | 0.0000556 | 0.0000545 |
South Asian | 0.0000665 | 0.0000654 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May act as an inhibitor of TGF-beta signaling. {ECO:0000269|PubMed:15247411}.;
Recessive Scores
- pRec
- 0.104
Intolerance Scores
- loftool
- 0.104
- rvis_EVS
- 0.05
- rvis_percentile_EVS
- 57.48
Haploinsufficiency Scores
- pHI
- 0.328
- hipred
- N
- hipred_score
- 0.322
- ghis
- 0.518
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.866
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Vasn
- Phenotype
- liver/biliary system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; homeostasis/metabolism phenotype; cellular phenotype;
Gene ontology
- Biological process
- negative regulation of epithelial to mesenchymal transition;negative regulation of transforming growth factor beta receptor signaling pathway;cellular response to hypoxia;cellular response to redox state
- Cellular component
- extracellular space;mitochondrion;lysosomal membrane;plasma membrane;cell surface;integral component of membrane;extracellular matrix;extracellular exosome
- Molecular function
- protein binding;cadherin binding;transforming growth factor beta binding